Alison Todd ISCT ANZ - BAA Joint Scientific Meeting 2022

Alison Todd

Alison Todd co-founded SpeeDx in 2009 and is its Chief Scientific Officer. She is an elected Fellow of the Australian Academy of Technology and Engineering and in 2020 was the co-recipient of academy’s Clunies Ross Innovation Award for “discovery, development, and adoption of a technology that has significantly improved societal or industry capabilities”. Alison’s career has focused on developing and commercialising diagnostic tools for tailoring and monitoring therapy for patients with cancer or infectious diseases. She is a serial inventor with over 94 granted patents, and her inventions underpin SpeeDx’s range of regulatory-approved, human IVD tests which are sold globally. Prior to founding SpeeDx, Alison spent nearly 20 years within the pharmaceutical industry and was a Senior Research Director at Johnson and Johnson Research Pty Limited, Sydney. She obtained her PhD through the University of Sydney and maintains an active involvement with the academic community through her appointment as an Adjunct Professor at the University of New South Wales.